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Rheumatoid factors (RFs)' are autoantibodies that bind to antigenic determi-
nants on the Fc portion of autologous IgG found in sera and synovial fluids of
most patients with adult rheumatoid arthritis (RA). These antibodies are not
specific for RA and are seen in other autoimmune conditions, as well as in
patients with certain bacterial, viral, and parasitic infections, and at low titer in
many normal individuals. The inciting stimuli and mechanisms for their produc-
tion in each of these situations are unknown .
Recent studies (1, 2) have shown that the site on IgG Fc regions that binds to
IgG and IgM RFs from patients with RA is in the same location and involves
some of the same amino acid residues as the site that binds to staphylococcal
protein A (SPA). Streptococcal Fc binding proteins also appear to bind to the
same location (3, 4), and Fc binding proteins with the same specificity have been
demonstrated on cells infected with herpes virus type I (5).
The binding site similarities between RFs and microbial Fc binding proteins
suggested conformational similarities between the antigen-combining site of RFs
and the Fc binding sites of these microbial structures (1, 4). In this report we
demonstrate that antibodies to SPA bind to a shared idiotypic determinant on
human IgM and IgG RFs, indicating that RFs carry the internal image of this
bacterial Fc binding protein.
Materials and Methods
Preparation ofIgM and IgG RFs and Non-RF Igs and Fc Fragments.
￿
IgM and IgG RFs
from patients with RA were isolated using previously described methods (1, 6). Briefly,
sera from patients with RA were passed over IgG affinity columns in borate buffer (0 .2
M borate, 0.15 M NaCl, pH 8.8), and the adsorbed RFs were eluted with 0.1 M acetate,
pH 3.5. The eluted RFs were then gel filtered on Sephacryl S-300 (Pharmacia Fine
Chemicals, Piscataway, NJ) in acetate buffer (0.1 M acetate, 0.15 M NaCl, pH 3.5) to
separate IgM RFs and IgG RFs. Serum containing a monoclonal IgM with RE activity
from a patient with a lymphoproliferative disorder (Jan) was provided by Dr. Harvinder
Luthra, Mayo Clinic, Rochester, MN. Jan IgM RF was prepared by affinity chromatog-
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raphy and gel filtration as described for RA sera. Isolated RFs were then dialyzed into
borate buffer. Some isolated RFs were stored at -70 °C before use.
IgM RFs from patients with cryoglobulinemia were isolated by cryoprecipitation.
Cryoprecipitates were washed three times with chilled borate buffer, solubilized, and gel
filtered on Sephacryl S-300 in acetate buffer, or applied to an HPLC (Waters Associates,
Milford, MA) gel filtration column (Protein Pak 300 SW; Waters Associates) equilibrated
in acetate buffer, pH 3.5. RF activity of the isolated proteins was assayed by latex
agglutination or by ELISA. Plasma from patients Les and Pal were provided by Dr.
Dennis Carson, Scripps Clinic and Research Foundation, La Jolla, CA.
Non-RF IgMs were isolated from patients with monoclonal IgM gammopathy by
preparative starch block electrophoresis and S-300 gel filtration. Purified polyclonal IgM
(Behring Diagnostics, San Diego, CA) was purchased. Polyclonal IgG was prepared by
DEAE ion-exchange chromatography and gel filtration of human Cohn fraction II (Miles
Scientific Div., Naperville, IL).
Fc fragments of IgG were prepared and isolated from papain digested human IgG as
described previously (6).
Preparation of Chicken Ig.
￿
Affinity-purified chicken anti-SPA (Accurate Chemical &
Scientific Corp., Westbury, NY) and chicken gamma globulin (Sigma Chemical Co., St.
Louis, MO) were assayed for SPA binding by double immunodiffusion before use. A
single precipitin line formed between SPA and chicken anti-SPA, but not with chicken
gamma globulin . To exclude the possibility of contaminating SPA in the affinity isolated
preparation, both chicken anti-SPA and chicken gamma globulin were passed over a
human IgG affinity column in borate buffer, pH 8.0, and the fall-through fraction was
used in ELISA. No contaminating human IgG was detected in either preparation by a
sensitive ELISA using peroxidase-conjugated rabbit antibodies to human Fcy (Cooper-
Biomedical, Inc., Malvern, PA) as the detecting reagent.
Pepsin-digested chicken gamma globulin and chicken anti-SPA were prepared by
incubating chicken proteins in 0.1 M acetate buffer, pH 4.5, with pepsin (Worthington
Biochemical Corp., Freehold, NJ) at a 1 :25 pepsin/protein weight ratio for 16 h at 37°C.
Previous studies (7) have shown that pepsin digestion of chicken Igs at pH 4.5 yields
predominantly Fab' fragments rather than F(ab')2 fragments. The digestion mixtures
were applied to an HPLC gel-filtration column (Superose 12; Pharmacia Fine Chemicals).
Pepsin-digested chicken gamma globulin and chicken anti-SPA each yielded major peaks
of ^-50 kD. These isolated peaks were used to coat microtiter wells in an ELISA assay .
Enzyme Linked Immunosorbent Assays (FLISA). Chicken anti-SPA and nonimmune
chicken gamma globulin were shown to coat flat-bottomed microtiter plates (Nunc
Immunoplate II; Scientific Resource Associates, Bellevue, WA) equivalently, as detected
with biotinylated rabbit anti-chicken IgG in a preliminary ELISA. Assays for binding of
human Igs to chicken anti-SPA and chicken gamma globulin were performed as follows.
Microtiter plate wells were coated by overnight incubation with chicken Igs using 50
,ul/well at 25 mg/ml in 0.1 M bicarbonate buffer, pH 9.6. After washing three times with
0 .5% Tween 20 (J. T. Baker Chemical Co., Phillipsburg, NJ) in borate buffer, human
non-RF IgM, IgG, or RF preparations were added at 50,ug/ml in 0.05% Tween-borate
buffer pH 8.0 and incubated overnight at 4°C. After washing, horseradish peroxidase-
conjugated F(ab')2 of goat antibodies to human F(ab')2 of IgG (CooperBiomedical, Inc.),
diluted 1 :3,000 in 0 .05% Tween, 0.3% BSA in borate buffer were added and incubated
3 h at room temperature. These detecting antibodies bound both human IgG and IgM.
After a final wash, the peroxidase substrate 2,2'-azino-di-[3-ethyl-benzthiazoline sulfonate]
and H 202 were added and absorbance at 405 nm was detected on a plate reading
spectrophotometer (Bio-Tek Instruments, Inc., Burlington, VT) . All samples were run in
duplicate and control wells were included in each assay to exclude nonspecific adsorption.
Background binding of peroxidase-conjugated goat anti-human F(ab')2 to chicken anti-
SPA and to chicken gamma globulin were identical and were subtracted from experimental
values. SPA and fragment D inhibition assays were performed by adding dilutions of SPA
(Sigma Chemical Co.) and fragment D (generously provided by Dr. John Sj6quist,
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the addition of IgM RE The preparations of SPA and fragment D were shown to be free
of human IgG by RIA.
Inhibition of chicken anti-SPA binding to IgM RF by human IgG and human Fc was
tested in an assay in which F(ab')2 of rabbit antibodies to chicken IgG (CooperBiomedical,
Inc .) were used to detect binding. In this assay, IgM RFs were used to coat microtiter
wells at a concentration of 30 Ag/ml in bicarbonate buffer. After washing, dilutions of
human IgG, Fc fragment of IgG, or BSA in 0.05% Tween-borate buffer were added to
wells and incubated overnight at 4°C . Chicken anti-SPA or chicken gamma globulin was
then added at a concentration of 50,ug/ml in Tween-borate buffer and plates were again
incubated overnight. After washing, biotinylated F(ab')2 of rabbit antibodies to chicken
IgG were added at a dilution of 1 :1,000 in 0.05% Tween-borate buffer and incubated 3
h at room temperature. Plates were again washed, and peroxidase-conjugated avidin
(Sigma Chemical Co.) was added at a 1 :1,000 dilution in 0.05% Tween-borate buffer
containing 0.3% BSA. For each dilution of inhibitor, absorbance of chicken gamma
globulin-containing wells was subtracted from the absorbance of chicken anti-SPA-
containing wells to eliminate background binding.
Inhibition curves were generated by fitting the observed data to the binding equation:
P = [(Kd,a X P,;) + (I X P,ax)]/(Kd,o + I), where P is the absorbance at 405 nm; Pm; is the
asymptote at low 1; P,- is the asymptote at high 1; Kd,, represents the dissociation constant,
and is equal to I when P is 50% of control binding; I is the concentration of inhibitor.
The fitting was accomplished with a computer program using a weighted nonlinear least-
squares function (1) .
Results
Binding of Human IgM and IgG RFs to Chicken Anti-SPA.
￿
Nineteen isolated
IgM RFs, two IgG RFs, three monoclonal IgM preparations without RF activity,
polyclonal non-RF IgM, and a polyclonal non-RF IgG preparation were tested
for binding to chicken anti-SPA and chicken gamma globulin. 18 of the 19 RF
preparations showed significant binding to chicken anti-SPA. Five of these (Moe,
Hou, Van, Sch, EG) were IgM RFs isolated from sera of patients with RA. 13
IgM RFs were isolated from cryoglobulins of patients with mixed cryoglobuli-
nemia. The monoclonal cryoglobulins Les and Pal bear the major crossreactive
idiotypes Po and Wa, respectively (Carson, D., personal communication). These
RFs differ from one another in their expression of primary sequence dependent
light chain idiotypes (8), yet both bind to chicken anti-SPA. One preparation
(Jan), a monoclonal noncryoglobulin IgM with RF activity from a patient with a
lymphoproliferative disorder, did not bind significantly to chicken anti-SPA.
Two IgM preparations without RF activity from patients with Waldenstrom's
macroglobulinemia (Gil, Dok) and a non-RF IgM cryoglobulin isolated from a
patient with Type I cryoglobulinemia (Eri), as well as polyclonal non RF human
IgG and IgM, also did not bind significantly to chicken anti-SPA (Fig. 1). Two
polyclonal IgG RFs were also tested for binding to chicken anti-SPA. These IgG
RFs were derived from sera of patients with RA whose IgM RFs bound chicken
anti-SPA (Moe, Hou). Both IgG RFs bound chicken anti-SPA but not chicken
gamma globulin. Polyclonal human non RF IgG showed insignificant binding to
anti-SPA (Fig. 2).
Chicken antibodies were used in these assays because Igs from that species do
not bind to SPA (9). Most of the RFs also did not bind significantly to chicken
Ig, although five IgM RFs showed low-level binding (Eva, Buc, Les, Moe, Sch).
This may suggest heterogeneity in the binding site specificity of these RF





Binding of polyclonal human IgG, polyclonal human IgM, non-RF IgM from
three individuals (Gil, Eri, Dok), and isolated IgM RF from 19 individuals to affinity-purified
chicken anti-SPA (often bars) and nonimmune chicken gamma globulin (solid bars) in ELISA .
Presence (+) or absence (-) ofRE activity is indicated below the letter codes of the specimens .
Error bars indicate absorbance at 405 nm of duplicate wells . Les and Pal represent members
of Po and Wa crossreactive idiotypic groups, respectively .
FIGURE 2 .
￿
Binding of polyclonal human IgG and IgG RFs from
two individuals with RA (Moe, Hou) to affinity-purified chicken
anti-SPA (open bars) andnonimmune chickengamma globulin (solid
bars) in ELISA . For these patients, substantial binding of both IgM
RFs (Fig . 1) and IgG RFs to chicken anti-SPA was observed.
FIGURE 3 .
￿
Binding of polyclonal human IgG, polyclonal hu-
man IgM, and isolated IgM RFs from three individuals (Moe,
Ple, Buc) to Fab' fragmentsof chicken anti-SPA (open bars)and
nonimmune chicken gamma globulin (solid bars) in ELISA .
To exclude nonspecific binding of the RFs to chicken IgG via the Fc region,
binding of three RFs was tested to Fab' fragments of chicken anti-SPA and
chicken gamma globulin . These experiments showed that the tested RFs bound
to pepsin-digested chicken anti-SPA and not to pepsin-digested chicken gamma
globulin . Polyclonal human non-RF IgM and IgG did not bind significantly to
the Fab' fragments of anti-SPA (Fig. 3) . When SPA was added to wells coated
with Fab' fragments of anti-SPA, polyclonal IgG binding could then be detected,
indicating that these fragments retained antigen-binding activity when used to
coat microtiter wells (data not shown) . Fab' fragments ofnormal chickengamma
globulin bound neither RFs nor SPA.706 RHEUMATOID FACTORS BEAR THE INTERNAL IMAGE OF PROTEIN A
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FIGURE 4 .
￿
Inhibition of binding of Moe IgM RF to
solid-phase chicken anti-SPA by SPA (squares) and
fragment D of SPA (circles). Error bars indicate stan-
dard deviations of duplicate wells.
FIGURE 5.
￿
Inhibition of bindingof chicken anti-SPA to
solid-phase Hou IgM RF by IgG (filled squares) and Fc
fragment of IgG (open squares). Theeffect ofaddition of
BSA, an unrelatedprotein, at comparable molar concen-
trations is shown for comparison (triangles). Error bars
indicate standard deviations of duplicate wells.
Inhibition with SPA, Fragment D ofSPA, and Human IgG.
￿
To demonstrate that
the antigen-combining sites on chicken anti-SPA as well as on IgM RFs were
involved in the interaction of chicken anti-SPA and IgM RFs, inhibition assays
using SPA, the 7-kD fragment D of SPA, and IgG Fc were performed.
Binding of Moe IgM RF to chicken anti-SPA was inhibited by the addition of
SPA and by the monovalent fragment D of SPA (Fig. 4). 50% inhibition (Kd5a ±
SEM) of IgM RF binding occurred at an SPA concentration of 0.017 ± 0.002
AM and at a fragment D concentration of 13 .72 ± 2.21 AM . Using a sensitive
RIA, we have found that several commercially available preparations of SPA
contain trace amounts of IgG, resulting possibly from use of IgG affinity columns
for their isolation (data not shown). The SPA preparation used in these assays
was free of IgG contamination by RIA.
The interaction of chicken anti-SPA and IgM RF was also inhibitable by
human Fc and human IgG. As compared with inhibition using SPA, much higher
concentrations of IgG were required for inhibition . This probably reflects the
relatively low binding affinity of RFs for monomeric IgG in solution. Inhibition
of chicken anti-SPA binding to Hou IgM RF is shown in Fig. 5. 50% inhibition
(Kd,n i - SEM) of Hou IgM RF binding occurred at an IgG concentration of 32 .58
± 8.27 AM and at an Fc concentration of 27.71 ± 2.67 AM. Chicken anti-SPA
binding to Moe IgM RF was also inhibitable by Fc of IgG, with a Kd5a ± SEM of
80.71 ± 12 .08 AM . An unrelated protein, BSA, added at comparable molar




The obtained resultsindicate that human RFs from different individuals share
a determinant that is recognized by antibodies to SPA, suggesting a conforma-
tional resemblance of these human autoantibodies to an Fc binding protein of
microbial origin . The presence of this determinant on 18 of 19 IgM RFs,
including members of the Po (Les) and Wa (Pal) crossreactive idiotype groups,
as well as on two IgG RFs, and its absence on non-RF Igs suggest that the site
recognized by anti-SPA is an idiotypic determinant related to the combining site
of these antibodies. This is further supported by inhibition of the interaction of
anti-SPA and IgM RF by Fc. Despite differences in the primary structures of
RFs, broadly crossreactive "internal image" antiidiotypic antibodies against a
conformational binding site determinant on human RFs have been elicited in
rabbits by immunization with polyclonal or monoclonal RFs (10). Idiotypic
network theory suggests that idiotypic determinants on antibodies can mimic
exogenous antigens (11). The data presented here, combined with the observa-
tion that SPA and many human RFs show similar IgG binding properties and
bind to a site at the Cy2-Cy3junction of human Fc (1, 2), suggest that RFs carry
the conformational internal image of the site on SPA that binds to the Fc region
of human IgG.
Because these findings are based on antigen-antibody interactions in a sensitive
ELISA, care was taken to exclude detection of trace contaminants or nonspecific
interactions. We considered the possibility that small amounts of SPA present in
the affinity-isolated anti-SPA preparation could bind to any IgG contaminating
the IgM RF isolates. Possible contaminating SPA was eliminated by passing both
the chicken anti-SPA and chicken gamma globulin over a human IgG affinity
column before use. The affinity-purified chicken anti-SPA did not bind to human
IgG in the ELISA. The presence of contaminating human IgG in the chicken
anti-SPA was also carefully excluded, as we have found that a 1% contamination
with IgG can result in detectable RF binding in our ELISA assay. No human
IgG was detected in the anti-SPA preparation in a sensitive ELISA using perox-
idase-conjugated goat or rabbit antibodies to human IgG Fc or F(ab')2 as
detecting reagents, with nonimmune chicken gamma globulin as a negative
control.
RFs are associated with a variety of conditions both in humans and experimen-
tal animals. They have been observed in the course of chronic infections in
humans (12, 13) and after repeated immunization with bacterial cell walls in
animals (14). The appearance of IgM RF during anamnestic immune responses
to protein antigens in mice (15, 16) and after immunization in humans (17)
suggests that they may participate in normal immunoregulatory or inflammatory
responses. The precise mechanisms for RF production in humans are unknown.
RFs produced in normal individuals and RFs associated with autoimmune dis-
eases, such as rheumatoid arthritis, appear to differ in their idiotype expression,
as defined by mAbs to structural determinants (8). In RA, RFs are produced in
inflamed synovium and are of IgG, IgA, and IgM isotypes (18). These observa-
tions raise the possibility that different mechanisms of RF production exist in
various conditions. In mice, several mechanisms of RF production have been
demonstrated or proposed . Polyclonal B cell activators induce RF production in708 RHEUMATOID FACTORS BEAR THE INTERNAL IMAGE OF PROTEIN A
a T cell-independent manner in both normal and nude mice (15, 19). RF
produced in mice after immunization with immune complexes requires T cell
participation and is specific for the subclass of immunizing Ig (14, 15). RF
production in 129/Sv mice appears to involve a filterable intestinal infectious
agent and is also of restricted IgG subclass specificity (20). Finally, reactivity of
certain mouse antibodies with both Fc fragments(RF activity) and Fab fragments
ofantibodies suggests that RFs might arise as part of an idiotypic network (21,
22).
It has been suggested (23, 24) that autoantibodies may arise as antiidiotypic
antibodies to exogenousantigens. Ifthe RF binding site conformationally resem-
bles Fc binding structures on microbial agents, then, given the appropriate
immunogenetic background, RFs could arise as internal image antiidiotypic
antibodies in the course of an immune response to certain infections . The
hypothesis that RFs may be produced as antiidiotypic antibodies against antibod-
ies to microbial Fc receptors has been proposed by us (1, 4) and by others (25,
26). A similar mechanism has been demonstrated to result in production of
antibodies to hormone receptors. Immunization of mice with insulin resulted in
the production of antiidiotypic antibodies that mimicked insulin in binding to
cellular insulin receptors (27). Alternatively, the immune response to microbial
Fc-binding proteins could induce or modulate rheumatoid factor production
through other mechanisms.
There is some evidence to suggest that modulation ofautoantibody production
through perturbation of the idiotype-antiidiotype network occurs after bacterial
infections. The transient appearance of antiidiotypic antibodies to a human RF,
accompanied by a marked reduction in rheumatoid factor activity of the serum
of a patient with mixed cryoglobulinemia, has been reported in association with
pneumococcal bacteremia (28). An idiotypic connection between antibodies to
the a-1,3-dextran determinant on certain bacteria and autoantibodies to the
acetylcholine receptor has been proposed as a mechanism for the initiation of
autoimmunity in myasthenia gravis (29). Antiidiotypic serum from mice and
rabbits immunized with human RFs has been shown to react with a cell wall
peptidoglycan preparation from group A Streptococcus pyogenes (30) . This may
indicate the presence of more than one crossreactive idiotypic determinant on
RFs that is also present on some bacteria. Alternatively, it is possible that small
amounts of the group A streptococcal Fc-binding protein contaminating the
peptidoglycan preparation could crossreact with RFs in a manner resembling
SPA (4).
The data presented herein show that a subset of chicken antibodies to SPA
bind to human RFs. It will be important todetermine whether similar RF binding
antibodies arise in humans in the course ofthe immune response to SPA or other
microbial Fc-binding proteins and whether such antibodies can induce or mod-
ulate RF production.
Summary
The binding specificity of rheumatoid factors (RFs) to human Fc resembles
thatofsomemicrobial Fc-binding proteins, suggesting conformational similarities
in their Fc-binding regions. Using polyclonal chicken antibodies against SPA, wehave detected a crossreactive determinant shared by human RFs from different
individuals, but not by non-RF IgM and IgG. Chicken anti-SPA was shown to
bind to 18 of 19 IgM RFs and 2 of 2 IgG RFs isolated from different individuals .
This binding was inhibitable with SPA, fragment D of SPA, human IgG, and Fc
fragment of IgG. The binding site for RF was located on the Fab' fragment of
chicken anti-SPA. The antigenic mimicry of RFs by a protein of microbial origin
suggests that the immune response to infectious agents could induce or modulate
RF production through an internal image autoantiidiotype mechanism.
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